FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 22 May 2015.
Product details
- Category: Human Drugs
- Number of Observations: 3
- Inspection end: 22 May 2015
- Location: Thousand Oaks, United States
- FEI: 2026154
